What happenedAccording to a Securities and Exchange Commission (SEC) filing dated October 29, 2025, Patient Capital Management, LLC increased its position in Precigen (PGEN +2.22%) by 10.2 million shares during Q3 2025. The estimated transaction value was $28.78 million, based on the average closing price for the quarter. The fund now holds approximately 26.5 million shares, worth$87.06 million.What else to knowTrade direction: buy; position now 3.48% of reported 13F assets under managementTop holdings aft ...